Literature DB >> 8929429

Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease.

C Winkler1, H Sauer, C S Lee, A Björklund.   

Abstract

Glial cell line-derived neurotrophic factor (GDNF) has been shown to exert neuroprotective effects on dopamine (DA) neurons in vivo. Here we report long-term rescue of nigral DA neurons after delayed short-term GDNF administration in a rat lesion model that reproduces the slowly progressing degenerative process seen in Parkinson's disease. GDNF injected close to the substantia nigra provided near-complete protection and persistent survival of the lesioned nigral neurons for at least 4 months after discontinuation of GDNF treatment. Long-term rescue of the nigral cells, however, was not accompanied by any significant reinnervation of the lesioned striatal target or any signs of functional recovery in either drug-induced or spontaneous motor behaviors. We conclude that not only preservation of the nigral DA neurons but also restoration of striatal DA function is necessary for functional recovery in the rat Parkinson model.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8929429      PMCID: PMC6578933     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  25 in total

1.  Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

Authors:  U Ungerstedt; G W Arbuthnott
Journal:  Brain Res       Date:  1970-12-18       Impact factor: 3.252

2.  Intracerebral grafting of neuronal cell suspensions. IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites.

Authors:  S B Dunnett; A Björklund; R H Schmidt; U Stenevi; S D Iversen
Journal:  Acta Physiol Scand Suppl       Date:  1983

3.  Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test.

Authors:  M Olsson; G Nikkhah; C Bentlage; A Björklund
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

4.  The Importance of Graft Placement and Task Complexity for Transplant-Induced Recovery of Simple and Complex Sensorimotor Deficits in Dopamine Denervated Rats.

Authors:  Ronald J. Mandel; Patrik Brundin; Anders Björklund
Journal:  Eur J Neurosci       Date:  1990       Impact factor: 3.386

Review 5.  Dendritic release of dopamine in the substantia nigra.

Authors:  A Cheramy; V Leviel; J Glowinski
Journal:  Nature       Date:  1981-02-12       Impact factor: 49.962

6.  Rate of cell death in parkinsonism indicates active neuropathological process.

Authors:  P L McGeer; S Itagaki; H Akiyama; E G McGeer
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

7.  'Disengage' sensorimotor deficit following apparent recovery from unilateral dopamine depletion.

Authors:  T Schallert; S Hall
Journal:  Behav Brain Res       Date:  1988-09-01       Impact factor: 3.332

Review 8.  Dopamine receptor interactions: some implications for the treatment of Parkinson's disease.

Authors:  H A Robertson
Journal:  Trends Neurosci       Date:  1992-06       Impact factor: 13.837

9.  Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

Authors:  H Sauer; W H Oertel
Journal:  Neuroscience       Date:  1994-03       Impact factor: 3.590

10.  Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.

Authors:  K E Bowenkamp; A F Hoffman; G A Gerhardt; M A Henry; P T Biddle; B J Hoffer; A C Granholm
Journal:  J Comp Neurol       Date:  1995-05-15       Impact factor: 3.215

View more
  36 in total

1.  Role for GDNF in biochemical and behavioral adaptations to drugs of abuse.

Authors:  C J Messer; A J Eisch; W A Carlezon; K Whisler; L Shen; D H Wolf; H Westphal; F Collins; D S Russell; E J Nestler
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

2.  Restorative plasticity of dopamine neuronal transplants depends on the degree of hemispheric dominance.

Authors:  G Nikkhah; G Falkenstein; C Rosenthal
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

3.  GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis.

Authors:  C M Kearns; W A Cass; K Smoot; R Kryscio; D M Gash
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

Review 4.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

Review 5.  Neurotoxins as Preclinical Models for Parkinson's Disease.

Authors:  Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-01-08       Impact factor: 3.911

6.  Dopamine is produced in the rat spinal cord and regulates micturition reflex after spinal cord injury.

Authors:  Shaoping Hou; David M Carson; Di Wu; Michelle C Klaw; John D Houlé; Veronica J Tom
Journal:  Exp Neurol       Date:  2015-12-02       Impact factor: 5.330

Review 7.  Gene therapy for Parkinson's disease.

Authors:  P Horellou; J Mallet
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

8.  Cinnamon and its Metabolite Protect the Nigrostriatum in a Mouse Model of Parkinson's Disease Via Astrocytic GDNF.

Authors:  Dhruv Patel; Arundhati Jana; Avik Roy; Kalipada Pahan
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-22       Impact factor: 4.147

9.  Neuroprotective Effects of Antidepressants via Upregulation of Neurotrophic Factors in the MPTP Model of Parkinson's Disease.

Authors:  Sina Shadfar; Yu-Gyeong Kim; Nikita Katila; Sabita Neupane; Uttam Ojha; Sunil Bhurtel; Sunil Srivastav; Gil-Saeng Jeong; Pil-Hoon Park; Jin Tae Hong; Dong-Young Choi
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

10.  Dopamine neuron stimulating actions of a GDNF propeptide.

Authors:  Luke H Bradley; Josh Fuqua; April Richardson; Jadwiga Turchan-Cholewo; Yi Ai; Kristen A Kelps; John D Glass; Xiuquan He; Zhiming Zhang; Richard Grondin; O Meagan Littrell; Peter Huettl; Francois Pomerleau; Don M Gash; Greg A Gerhardt
Journal:  PLoS One       Date:  2010-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.